PRQR | ProQR Therapeutics N.V. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	3.46 - 3.70
52 Week Range	1.6100 - 4.62
Beta	0.89
Implied Volatility	205.25%
IV Rank	25.32%
Day's Volume	145,379
Average Volume	1,412,007
Shares Outstanding	103,204,000
Market Cap	366,374,200
Sector	Healthcare
Industry	Biotechnology
IPO Date	2014-09-18

Valuation
Profitability
Growth
Health
P/E Ratio	-11.09
Forward P/E Ratio	N/A
EPS	-0.32
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	156
Country	Netherlands
Website	PRQR

ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clinical trial to treat USH2A-mediated retinitis pigmentosa and usher syndrome. The company also engages in the developing of Axiomer RNA base-editing platform technology. It has a license agreement with Radboud University Medical Center, Inserm Transfert SA, Ionis Pharmaceuticals, Inc., and Leiden University Medical Center, as well as license and research collaboration with Eli Lilly and Company for the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system. ProQR Therapeutics N.V. was incorporated in 2012 and is headquartered in Leiden, the Netherlands.

PRQR's peers: ALNY, ARWR, ANNX, DAWN, TERN, WVE, BPMC, APLS, ASMB, SPRO, ACHL, TIL, NLTX, CTMX, NXTC, NUVB, TCRX, VYGR, ZYME

*Chart delayed

Analyzing fundamentals for PRQR we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is very bad and Health is weak. For more detailed analysis please see PRQR Fundamentals page.

Watching at PRQR technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on PRQR Technicals page.